Bridging the New Treatment Gap: What Will it Take?

New WHO guidelines for the treatment of HIV released in July 2013 recommend that treatment start earlier, and more people living with HIV be eligible for treatment. This will result in greater demand for treatment, among other commodities and services. In this meeting we aim to discuss the implications of this new demand for treatment, and the state of industry readiness, identifying key challenges and opportunities.


A joint Medicines Patent Pool & World Health Organization Satellite on the occasion of the WHO-UNICEF-UNFPA meeting in Copenhagen, Denmark 23-25 September 2013

17:30-18:00 Pre-meeting refreshments
18:00-18:10 Welcome by the Chairs
Co-Chair: Greg Perry, Executive Director, Medicines Patent Pool
Co-Chair: Joseph Perriens, Coordinator, Technology and Commodities for HIV, WHO
18:10-18:20 State of industry readiness for the new demand following the new treatment guidelines
Speaker: Louis Riceberg, BioBridge Strategies
18:20-18:30 Challenges and opportunities in paediatric treatment arising out of the new treatment guidelines
Speaker: Atieno Ojoo, Technical Specialist, Medicines and Nutrition Center, UNICEF Supply Division
18:30-18:40 Regulatory complexities, opportunities and working with them
Speaker: Lembit Rago, Head, Regulation of Medicines and Health Technologies, WHO Department of Essential Medicines and Health Products
18:40-18:50 Working together to achieve access goals: experience of industry collaborations to achieve access goals
Speaker: Scott Purdon, Director, Access and Government Affairs, ViiV Healthcare
18:50-19:10 Panel Discussion
Speakers: Umesh K, Aurobindo Pharma Limited; Sandeep Juneja, Medicines Patent Pool; Gitanjali Sakhuja, UNICEF
19:10-19:30 Q&A and closing
19:30 Light buffet dinner